You are here: Home > Prescription(RX) Drugs > L > Lidocaine Hcl (Kylemore Pharmaceuticals, Llc)|
lidocaine hydrochloride cream
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------Lidocaine HCl 3% Cream
Contains lidocaine HCl 3% in a mild acidic vehicle. Lidocaine is chemically designated as acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl), and has the following structure:
Each gram of Kylemmore Lidocaine HCl 3% Cream contains Lidocaine HCl USP 3%, Inactive Ingredients include: Purified Water, White Petrolatum USP, Stearic Acid NF, Cetyl Alcohol NF, Propylene Glycol USP, Stearyl Alcohol NF, Mineral Oil USP, Polysorbate 60, Sorbitan Monostearate, Methylparaben NF, Propylparaben NF, Sodium Hydroxide NF, Aluminum Sulfate and Calcium Acetate.
MECHANISM OF ACTION: Kylemmore Lidocaine HCl 3% releases lidocaine from a mild acidic vehicle to stabilize the neuronal membrane by inhibiting the ionic fluxes required for initiation and conduction of impulses, thereby effecting local anesthetic action. A mild acidic vehicle lowers pH to increase protection against alkaline irritations and to provide a favorable environment for healing.
Lidocaine may be absorbed following topical administration to mucous membranes, its rate and extent of absorption depending upon the specific site of application, duration of exposure, concentration and total dosage. In general, the rate of absorption of local anesthetic agents following topical application occurs most rapidly after intratracheal administration. Lidocaine is also well-absorbed from the gastrointestinal tract, but little intact drug appears in the circulation because of biotransformation in the liver.
Anti-inflammatory anesthetic for relief of pruritus, pruritic eczemas, abrasions, minor burns, insect bites, pain, soreness and discomfort due to pruritus ani, pruritus vulvae, hemorrhoids, anal fissures, and similar conditions of the skin and mucous membranes.
Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
If irritation of sensitivity occurs or infection appears, discontinue use and institute appropriate therapy. Kylemore Lidocaine HCl 3% Cream should be used with caution in ill, elderly, debilitated patients and children who may be more sensitive to the systemic effects of lidocaine.
CARCINOGENESIS, MUTAGENESIS AND IMPAIRMENT OF FERTILITY:
Studies of lidocaine in animals to evaluate the carcinogenic and mutagenic potential of the effect on fertility have not been conducted.
USE IN PREGNANCY:
Teratogenic Effects; Pregnancy Category B. Reproduction studies have been performed for lidocaine in rats at doses up to 6.6 times the human dose and have revealed no evidence of harm to the fetus caused by lidocaine. There are, however, no adequate and well-controlled studies in pregnant women. Animal reproduction studies are not always predictive of human response. General consideration should be given to this fact before administering lidocaine to women of childbearing potential, especially during early pregnancy when maximum organogenesis takes place.
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this drug is administered to a nursing mother.
Dosage in pediatric patients would be reduced commensurate with age, body weight and physical condition.
ADVERSE REACTIONS:During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.
DOSAGE AND ADMINISTRATION:
Apply a thin film to the affected area two or three times daily or as directed by a physician.
HOW SUPPLIED:Kylemmore Lidocaine HCl 3% Cream
1 oz. (28.3 g) tube - NDC 49769-105-01
3 oz. (85 g) tube - NDC 49769-105-03
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Store at controlled room temperature 20º-25ºC (68º-77º F).
Protect from freezing.
Port St. Joe, FL 32456
Revised: 03/2011 Kylemore Pharmaceuticals, LLC
Reproduced with permission of U.S. National Library of Medicine
Copyright © 2018
|Over-the-counter (OTC) Drugs|